A closer look at the safety and effectiveness of modern PORT in stage III-N2 non-small cell lung cancer

Charlotte Billiet*, Dirk De Ruysscher

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Original languageEnglish
Pages (from-to)E585-E586
Number of pages2
JournalJournal of Thoracic Disease
Volume9
Issue number6
DOIs
Publication statusPublished - Jun 2017

Keywords

  • POSTOPERATIVE RADIOTHERAPY
  • INDUCTION CHEMOTHERAPY
  • PHASE-III
  • RESECTION
  • TRIAL
  • NSCLC

Cite this